Sean Arlauckas

Senior Director, Cell Biology @Be Biopharma

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2024 — Present

Senior Director, Cell Biology @Be Biopharma

View department →

Cambridge, MA, US

We are building a team of passionate immunologists, exceptional genetic engineers, and motivated translational scientists. Join us on our quest to find life-saving cures for rare and infectious diseases, autoimmune disorders, and cancers with unmet needs

EDUCATION

N/A

University of Pennsylvania School of Medicine

Doctor of Philosophy (Ph.D.), Cancer Pharmacology, Molecular Imaging

N/A

Case Western Reserve University

B.S.E, Biomedical Engineering

N/A

Wheatland-Chili Central School

High School

SKILLS

Life SciencesTumor ModelsMolecular BiologyFluorescence MicroscopyIn VivoData AnalysisCell BiologyMicrosoft OfficePrimary Immune Cell AssaysCancerMouse DissectionCell CultureImmune OncologyCancer PharmacologyResearchBiochemistryMagnetic Resonance Imaging/SpectroscopyBiostatisticsIn Vivo Optical ImagingLipid MetabolismPcrAutomated Image AnalysisImmunohistochemistryPharmacokinetic ModelingBiomedical Engineering

ABOUT SEAN ARLAUCKAS

1st Employee at Be Biopharma - capable of setting up labs, teams, and company culture-invigorated by the uncertainty and promise of early-stage Biotech-proven record of productivity with ~10 provisional patents,~20 published papers, and ~50 conference abstracts-managed teams of 10+ direct reports -led initial tech transfer, DC-enabling studies, external innovation, and IP portfolio managementAn expert in target ID, validation and drug discovery with a particular focus on cancer immunotherapy, inflammation, and autoimmune and metabolic diseases.Areas of technical expertise include-In vitro pharmacology-Immune cell engineering-Single-cell transcriptomics, RNAseq of rare sorted populations, NanoString-Multiplexed assay optimization (flow cytometry, high content imaging) for in vitro characterization of primary immune cells-In vivo model development for preclinical pharmacology

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.